pti-6d2
mAbexperimentalADC
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2009 (NCT00734188)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
- Payload
- 188-Rhenium
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109673 ↗
- ChEMBLCHEMBL2109514 ↗
Also known as
- pti-188
- pti-6d2
- pti-6d2
- pti-6d2 (188re)
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00734188 | Phase 1 | Jan 1, 2009 | Cassava Sciences, Hebrew University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cassava Sciences | For profit | 1 | 1 | 1 | 2009 |
| Hebrew University | Academic/Hospital | 1 | 0 | 1 | 2009 |
2 organizations
Page 1 / 1